{"id":"W1974840376","doi":"10.1186/1471-2407-14-166","title":"Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study","year":2014,"lang":"en","type":"article","venue":"BMC Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Santé et de Services Sociaux de Chicoutimi; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Medicine; Trastuzumab; Tolerability; Sunitinib; Internal medicine; Adverse effect; Lapatinib; Breast cancer; Oncology; Clinical endpoint; Metastatic breast cancer; Cancer; Surgery; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002904003,0.001054365,0.002081667,0.0003876788,0.0003309131,0.0008033258,0.0006269105,0.0007889031,0.00203128],"category_scores_gemma":[0.0008961393,0.0003691192,0.001303443,0.0003858728,0.0005698511,0.0005402407,0.0002201164,0.001744729,0.000407673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006269326,"about_ca_system_score_gemma":0.00118622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004451176,"about_ca_topic_score_gemma":0.001021872,"domain_scores_codex":[0.9993852,0.000309173,0.00005195363,0.00008213116,0.0000856586,0.00008581903],"domain_scores_gemma":[0.9991366,0.0001686611,0.0002292144,0.00006534417,0.00006857063,0.0003316528],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4874099,0.09861149,0.02302425,0.002860316,0.006857042,0.0008022231,0.0006060908,0.00513244,0.09990329,0.0002372868,0.005064202,0.2694914],"study_design_scores_gemma":[0.4096709,0.5380172,0.03520532,0.0001063679,0.001950121,0.001055885,0.00006779667,0.001890362,0.007764511,0.0001246278,0.004099556,0.00004725119],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9919863,0.005125322,0.0005915852,0.0002256662,0.00005167799,0.0008364345,0.0003569153,0.00006943676,0.000756733],"genre_scores_gemma":[0.9920912,0.003442839,0.001101617,0.0004102401,0.0001446265,0.0008083038,0.001275871,0.00002602826,0.0006993515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002904003,"threshold_uncertainty_score":0.01535797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05524808339423454,"score_gpt":0.404221311925435,"score_spread":0.3489732285312005,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}